Christopher L. Carpenter, Chief Medical Officer at Rubius Therapeutics, Inc. (RUBY), sold 11,877 shares at $10.05 ($119K) on 2019-09-17, disclosed to the SEC on 2019-09-18.
Open-market sale of $119k RUBY by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RUBY | SELL | 2019-09-18 | $366K | — | Filing → |
| RUBY | SELL | 2019-06-24 | $3K | — | Filing → |
| RUBY | SELL | 2019-06-19 | $1.1M | — | Filing → |